BETH MORELAND: Open Payments
NPI 1407274780 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,932 in 109 payments from 26 companies in 2025. Trend: 2023 $1,630 · 2024 $2,494 · 2025 $1,932
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $290 |
| PFIZER INC. | 13 | $230 |
| AstraZeneca Pharmaceuticals LP | 10 | $197 |
| Lilly USA, LLC | 9 | $173 |
| Novo Nordisk Inc | 11 | $156 |
| Amgen Inc. | 11 | $154 |
| Daiichi Sankyo Inc. | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Antares Pharma, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
Products named: MOUNJARO, AIRSUPRA, NURTEC ODT, QULIPTA, VRAYLAR, INJECTAFER, REXULTI, KRYSTEXXA.
Industry payments across AZ — which companies pay providers there.
